191 related articles for article (PubMed ID: 9764839)
1. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.
Schilli MB; Paus R; Menrad A
J Invest Dermatol; 1998 Oct; 111(4):598-604. PubMed ID: 9764839
[TBL] [Abstract][Full Text] [Related]
2. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice.
Paus R; Schilli MB; Handjiski B; Menrad A; Henz BM; Plonka P
Cancer Res; 1996 Oct; 56(19):4438-43. PubMed ID: 8813138
[TBL] [Abstract][Full Text] [Related]
3. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
4. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
Peters EM; Foitzik K; Paus R; Ray S; Holick MF
J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291
[TBL] [Abstract][Full Text] [Related]
5. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
6. Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Shirai A; Tsunoda H; Tamaoki T; Kamiya T
J Dermatol Sci; 2001 Sep; 27(1):7-13. PubMed ID: 11457638
[TBL] [Abstract][Full Text] [Related]
7. Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles.
Kim MH; Kim K; Lee H; Yang WM
BMC Complement Med Ther; 2020 Jul; 20(1):230. PubMed ID: 32689985
[TBL] [Abstract][Full Text] [Related]
8. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.
Hendrix S; Handjiski B; Peters EM; Paus R
J Invest Dermatol; 2005 Jul; 125(1):42-51. PubMed ID: 15982301
[TBL] [Abstract][Full Text] [Related]
9. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
Ohnemus U; Unalan M; Handjiski B; Paus R
J Invest Dermatol; 2004 Jan; 122(1):7-13. PubMed ID: 14962083
[TBL] [Abstract][Full Text] [Related]
10. Plucking during telogen induces apoptosis in the lower part of hair follicles.
Matsuo K; Mori O; Hashimoto T
Arch Dermatol Res; 2003 Apr; 295(1):33-7. PubMed ID: 12709819
[TBL] [Abstract][Full Text] [Related]
11. Analysis of apoptosis during hair follicle regression (catagen).
Lindner G; Botchkarev VA; Botchkareva NV; Ling G; van der Veen C; Paus R
Am J Pathol; 1997 Dec; 151(6):1601-17. PubMed ID: 9403711
[TBL] [Abstract][Full Text] [Related]
12. Anticancer drugs induce apoptosis in mouse hair follicles.
Mori O; Matsuo K; Hashimoto T
Kurume Med J; 2000; 47(3):193-7. PubMed ID: 11059219
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
Paus R; Handjiski B; Eichmüller S; Czarnetzki BM
Am J Pathol; 1994 Apr; 144(4):719-34. PubMed ID: 8160773
[TBL] [Abstract][Full Text] [Related]
14. Alopecia of IFN-gamma knockout mouse as a model for disturbance of the hair cycle: a unique arrest of the hair cycle at the anagen phase accompanied by mitosis.
Hirota R; Tajima S; Yoneda Y; Tamayama T; Watanabe M; Ueda K; Kubota T; Yoshida R
J Interferon Cytokine Res; 2002 Sep; 22(9):935-45. PubMed ID: 12396715
[TBL] [Abstract][Full Text] [Related]
15. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice.
Chen SS; Zhang Y; Lu QL; Lin Z; Zhao Y
Environ Toxicol Pharmacol; 2016 Sep; 46():270-276. PubMed ID: 27522546
[TBL] [Abstract][Full Text] [Related]
16. Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
Sharov AA; Li GZ; Palkina TN; Sharova TY; Gilchrest BA; Botchkarev VA
J Invest Dermatol; 2003 Jan; 120(1):27-35. PubMed ID: 12535195
[TBL] [Abstract][Full Text] [Related]
17. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
[TBL] [Abstract][Full Text] [Related]
18. Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)?
Tobin DJ; Hagen E; Botchkarev VA; Paus R
J Invest Dermatol; 1998 Dec; 111(6):941-7. PubMed ID: 9856800
[TBL] [Abstract][Full Text] [Related]
19. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
